SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology | BioSpace Source Cluster: BioSpace Source Node: 3092730Time Stamp: Jan 31, 2024
SeaStar Medical Appoints David A. Green as Chief Financial Officer | BioSpace Source Cluster: BioSpace Source Node: 3059839Time Stamp: Jan 10, 2024
SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications | BioSpace Source Cluster: BioSpace Source Node: 3053353Time Stamp: Jan 8, 2024
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates Source Cluster: Fintech News Source Node: 3050900Time Stamp: Jan 7, 2024
SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury | BioSpace Source Cluster: BioSpace Source Node: 3039348Time Stamp: Dec 27, 2023
Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated Computational Design-Synthesis Platform for Peptide Drug Discovery Source Cluster: Fintech News Source Node: 2987419Time Stamp: Nov 30, 2023
Peijia Medical Presents Early Clinical Findings of GeminiOne® TEER Device at TCT 2023 | BioSpace Source Cluster: BioSpace Source Node: 2959616Time Stamp: Oct 26, 2023
Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative Source Cluster: Fintech News Source Node: 2953266Time Stamp: Oct 23, 2023
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients | BioSpace Source Cluster: BioSpace Source Node: 2889216Time Stamp: Sep 18, 2023
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder | BioSpace Source Cluster: BioSpace Source Node: 2887582Time Stamp: Sep 17, 2023
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region | BioSpace Source Cluster: BioSpace Source Node: 2869405Time Stamp: Sep 6, 2023
Femasys Inc. Obtains Medical Device Establishment License from Health Canada | BioSpace Source Cluster: BioSpace Source Node: 2860639Time Stamp: Aug 30, 2023
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan | BioSpace Source Cluster: BioSpace Source Node: 2851426Time Stamp: Aug 27, 2023
FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW) Source Cluster: Fintech News Source Node: 2848193Time Stamp: Aug 26, 2023